Paras Healthcare IPO Latest News
Paras Healthcare is set to launch its initial public offering on October 21, 2026, bringing one of India's hospital operators to the public market. The company has fixed the price band at ₹660 to ₹693 per share and aims to raise ₹1,450 crore through a combination of fresh equity issuance and an offer for sale.
Ahead of the public issue, Paras Healthcare raised ₹652.50 crore from anchor investors on October 19, with shares allotted at ₹693 each. The anchor book included domestic mutual funds and international institutional investors. The IPO will close on October 23, and the shares are tentatively scheduled to list on the BSE and NSE on October 28.
Paras Healthcare IPO Details
| Particular | Details |
|---|---|
| IPO Open Date | October 21, 2026 |
| IPO Close Date | October 23, 2026 |
| Price Band | ₹660–₹693 |
| Total Issue Size | ₹1,450 Cr |
| Fresh Issue | ₹500 Cr |
| Offer for Sale | ₹950 Cr |
| Face Value | ₹1 |
| Lot Size | 21 Shares |
| Minimum Investment | ₹14,553 |
| Expected Allotment | October 26, 2026 |
| Refund/Demat Credit | October 27, 2026 |
| Expected Listing | October 28, 2026 |
| Listing Platform | BSE and NSE |
| Registrar | MUFG Intime India |
The fresh issue will provide funds to the company, while the offer-for-sale portion will allow existing shareholders to sell part of their holdings. Investors should distinguish between these two components when assessing how the IPO proceeds will be used.
Paras Healthcare IPO GMP Today
The latest available grey-market update on October 20 reports a GMP of approximately ₹82 per share. At the upper price band of ₹693, this suggests an indicative price of ₹775.
| Particular | Latest Update |
|---|---|
| Upper Price Band | ₹693 |
| Reported GMP | ₹82 |
| Indicative Price | ₹775 |
| Indicative Premium | Around 11.83% |
| GMP Status | Unofficial |
GMP is an unofficial market indicator and can change before the listing. The indicative price is only an arithmetic estimate, not a guaranteed listing price or assured return.
Paras Healthcare IPO Anchor Investor Update
The company raised ₹652.50 crore through its anchor investor allocation on October 19, one day before the public issue opens. A total of 94,15,584 equity shares were allotted to 39 funds at ₹693 per share.
The participation of institutional investors provides an early indication of demand from selected investors, but it does not guarantee strong subscription across the retail and non-institutional categories once public bidding begins.
What Does Paras Healthcare Do?
Paras Healthcare operates a network of multispecialty hospitals under the Paras Health brand. Its hospitals provide tertiary and quaternary healthcare services, including specialist treatment for complex medical conditions.
As of June 30, 2026, the company operated eight hospitals with an aggregate capacity of 2,211 beds. Its network covers locations across North India, Bihar and Jharkhand, including Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar.
Paras Healthcare Business Overview
| Particular | Details |
|---|---|
| Business | Multispecialty Hospital Services |
| Brand | Paras Health |
| Number of Hospitals | 8 |
| Aggregate Bed Capacity | 2,211 |
| Key Specialties | Cardiac Sciences, Oncology, Neurosciences and Orthopaedics |
| Main Markets | North India, Bihar and Jharkhand |
| IPO Segment | Mainboard |
The company's specialty-led approach focuses on advanced medical treatment, diagnostic services, specialist consultations and hospital-based care. Its geographical presence also gives it exposure to healthcare demand in several urban and regional markets.
Paras Healthcare Financial Performance
Paras Healthcare has reported growth in its operating revenue. The company's standalone revenue for FY2026 was reported at approximately ₹1,368.09 crore, compared with ₹1,136.64 crore in FY2025.
| Particular | FY2025 | FY2026 |
|---|---|---|
| Standalone Revenue | ₹1,136.64 Cr | ₹1,368.09 Cr |
Investors should also review the company's consolidated financial statements, profitability, borrowings, cash flows and valuation metrics in the offer documents. Hospital businesses require substantial spending on medical equipment, infrastructure, staff and ongoing facility maintenance, so revenue growth alone does not provide a complete picture of financial performance.
Where Will Paras Healthcare IPO Funds Be Used?
The company has identified debt repayment and investment in its wholly owned subsidiary among the principal objectives of the fresh issue.
| Particular | Proposed Use |
|---|---|
| Repayment/Prepayment of Borrowings | ₹320.9 Cr |
| Investment in Subsidiary PMHPL for Debt Repayment | ₹54.1 Cr |
| General Corporate Purposes | Remaining Net Proceeds |
The proposed debt repayment is intended to reduce outstanding borrowing obligations at the company and its subsidiary. Lower debt could help manage future interest costs, although the ultimate impact will depend on the company's overall financial position and operating performance.
The ₹950 crore offer-for-sale component will go to the selling shareholders rather than being received by the company as fresh capital.
Paras Healthcare Growth Opportunities
Demand for specialised medical treatment, advanced diagnostics and tertiary healthcare services provides opportunities for established hospital networks. Paras Healthcare's presence across multiple cities allows it to serve patients seeking specialist care closer to their regions.
The company may benefit from improving healthcare access, rising demand for complex treatments and further utilisation of its existing hospital capacity. However, the pace of growth will also depend on medical staffing, patient volumes, operating costs and the ability to maintain treatment quality.
Key Risks to Track
Investors considering Paras Healthcare IPO should evaluate the following factors:
-
High operating costs: Hospitals require significant spending on doctors, nursing staff, medical equipment and facility maintenance.
-
Debt exposure: Borrowings and interest expenses can affect profitability and cash flow.
-
Regulatory requirements: Healthcare operations are subject to medical, safety, licensing and other compliance obligations.
-
Geographical concentration: Performance may be influenced by demand and competition in the company's operating markets.
-
Valuation: Investors should compare the IPO valuation with financial performance and listed hospital-sector peers.
-
Execution risk: Expansion and utilisation improvements depend on patient demand, staffing and operational efficiency.
These factors should be assessed alongside the company's offer documents rather than relying only on anchor demand or the grey-market premium.
Paras Healthcare IPO Timeline
| Particular | Date |
|---|---|
| Anchor Investor Allocation | October 19, 2026 |
| IPO Opening | October 21, 2026 |
| IPO Closing | October 23, 2026 |
| Basis of Allotment | October 26, 2026 |
| Refund Initiation | October 27, 2026 |
| Demat Credit | October 27, 2026 |
| Expected Listing | October 28, 2026 |
Final Update
Paras Healthcare IPO opens on October 21 with a total issue size of ₹1,450 crore. Its eight-hospital network, reported revenue growth and anchor investor fundraising are important points for investors to assess. The next major developments will be public subscription figures, category-wise demand and changes in the unofficial GMP during the three-day bidding period.
Disclaimer: GMP is an unofficial indicator and does not guarantee listing gains. Investors should review the official offer documents, financial performance, valuation and business risks before making an investment decision.
Loading comments...